Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
Clinical trial NCT03099265 · TERMINATED
Trial details
- NCT number
- NCT03099265
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2019-09-18
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.